Search Results - "Metter, G E"

Total Body Irradiation and High-Dose Etoposide: A New Preparatory Regimen for Bone Marrow Transplantation in Patients With Advanced Hematologic Malignancies by Blume, K.G., Forman, S.J., O’Donnell, M.R., Doroshow, J.H., Krance, R.A., Nademanee, A.P., Snyder, D.S., Schmidt, G.M., Fahey, J.L., Metter, G.E., Hill, L.R., Findley, D.O., Sniecinski, I.J.

“…In a phase I/II study, 47 patients (median age, 24 years) with hematologic malignancies (33 patients with acute leukemia not in first remission and 14 patients…”
Get full text

Morphological subclassification of follicular lymphoma: variability of diagnoses among hematopathologists, a collaborative study between the Repository Center and Pathology Panel for Lymphoma Clinical Studies by Metter, G E, Nathwani, B N, Burke, J S, Winberg, C D, Mann, R B, Barcos, M, Kjeldsberg, C R, Whitcomb, C C, Dixon, D O, Miller, T P

“…A collaborative study between the Repository Center for Lymphoma Clinical Studies and the members of the lymphoma pathology subcommittee of the major…”
Get more information

A prospective randomized study of acute graft-v-host disease in 107 patients with leukemia: methotrexate/prednisone v cyclosporine A/prednisone by Forman, S J, Blume, K G, Krance, R A, Miner, P J, Metter, G E, Hill, L R, O'Donnell, M R, Nademanee, A P, Snyder, D S

Get more information

Cyclophosphamide versus 5-fluorouracil, doxorubicin, and mitomycin C (FAM') in the treatment of hormone-resistant metastatic carcinoma of the prostate: a preliminary report of a randomized trial by Kasimis, B S, Miller, J B, Kaneshiro, C A, Forbes, K A, Moran, E M, Metter, G E

“…There is no evidence that combination chemotherapy is superior to single agents in the treatment of advanced, hormone-resistant carcinoma of the prostate. We…”
Get more information

Experience with continuous regional chemotherapy and hepatic resection as treatment of hepatic metastases from colorectal primaries. A prospective randomized study by Kemeny, M M, Goldberg, D A, Browning, S, Metter, G E, Miner, P J, Terz, J J

“…Sixty-five patients with hepatic metastases from colorectal primaries were studied in a prospective randomized fashion. The five patients with solitary…”
Get more information

High doses of prochlorperazine for cisplatin-induced emesis. A prospective, random, dose-response study by Carr, B I, Blayney, D W, Goldberg, D A, Braly, P, Metter, G E, Doroshow, J H

“…This study investigated the antiemetic properties of four different doses of prochlorperazine (10 mg, 20 mg, 30 mg, 40 mg) when given randomly to patients…”
Get more information

Bone marrow transplantation for acute nonlymphoblastic leukemia during first complete remission. An analysis of prognostic factors by Forman, S J, Krance, R A, O'Donnell, M R, Nademanee, A P, Snyder, D S, Fahey, J L, Schmidt, G M, Zaia, J A, Lipsett, J A, Findley, D O

“…Sixty-nine patients with acute nonlymphocytic leukemia in first remission received total-body irradiation and chemotherapy followed by allogeneic bone marrow…”
Get more information

Malignant Lymphoma, Mixed Cell Type, Diffuse by Nathwani, Bharat N., Metter, Gerald E., Gams, Richard A., Bartolucci, Alfred A., Hartsock, Robert J., Neiman, Richard S., Byrne, Gerald E., Barcos, Maurice, Kim, Hun, Rappaport, Henry

“…This retrospective study of diffuse mixed (DM) cell lymphoma was undertaken as a collaborative study between the Repository Center for Lymphoma Clinical…”
Get full text

An evaluation of colon cleansing regimens by Dodds, WJ, Scanlon, GT, Shaw, DK, Stewart, ET, Youker, JE, Metter, GE

“…To study the efficacy of colon cleansing regimens, 500 hospital outpatients were randomly assigned to one of four regimens. Two featured castor oil followed by…”
Get full text

What Should Be the Morphologic Criteria for the Subdivision of Follicular Lymphomas? by Nathwani, Bharat N., Metter, Gerald E., Miller, Thomas P., Burke, Jerome S., Mann, Risa B., Barcos, Maurice, Kjeldsberg, Carl R., Dixon, Dennis O., Winberg, Carl D., Whitcomb, Clarence C., Jones, Stephen E.

“…The members of the Pathology Panel for Lymphoma Clinical Studies undertook a collaborative study with the hope of resolving some of the controversies regarding…”
Get full text

Effects of amphotericin B with combination chemotherapy on response rates and on survival in non-small cell carcinoma of the lung by Presant, C A, Metter, G E, Multhauf, P, Bertrand, M, Chang, F F, Klein, L, Rappaport, D, Kendregan, B, Mackie, A

“…Thirty-seven patients with non-small cell carcinoma of the lung were randomized to receive doxorubicin, lomustine, hexamethylmelamine, and methotrexate (ACHM)…”
Get more information

Studies on adriamycin using a weekly regimen demonstrating its clinical effectiveness and lack of cardiac toxicity by Weiss, A J, Metter, G E, Fletcher, W S, Wilson, W L, Grage, T B, Ramirez, G

“…Adriamycin has been given to 442 patients using the weekly regimen as initially described by Bonadonna et al. Hematologic toxicity and clinical effectiveness…”
Get more information

What should be the morphologic criteria for the subdivision of follicular lymphomas? by Nathwani, BN, Metter, GE, Miller, TP, Burke, JS, Mann, RB, Barcos, M, Kjeldsberg, CR, Dixon, DO, Winberg, CD, Whitcomb, CC

“…The members of the Pathology Panel for Lymphoma Clinical Studies undertook a collaborative study with the hope of resolving some of the controversies regarding…”
Get full text

Phase I and preliminary phase II observations of high-dose intermittent 6-thioguanine by Presant, C A, Denes, A E, Klein, L, Garrett, S, Metter, G E

“…6-Thioguanine was administered iv or orally to 66 patients on an intermittent schedule, one dose every 3 weeks. Doses were gradually escalated until moderate…”
Get more information

Allogeneic bone marrow transplantation for acute lymphoblastic leukemia during first complete remission by Blume, K G, Forman, S J, Snyder, D S, Nademanee, A P, O'Donnell, M R, Fahey, J L, Krance, R A, Sniecinski, I J, Stock, A D, Findley, D O

“…Patients with acute lymphoblastic leukemia who have poor prognostic features at diagnosis usually have a short disease-free survival in spite of successful…”
Get more information

Mitotic counts in follicular lymphomas by Ellison, D J, Nathwani, B N, Metter, G E, Turner, R R, Burke, J S, Miller, T P, Mann, R B, Barcos, M, Kjeldsberg, C R, Winberg, C D

“…Increased mitotic activity is associated with significantly shorter patient survival in some of the subtypes of diffuse non-Hodgkin's lymphomas. This study on…”
Get more information

Malignant lymphoma, mixed cell type, diffuse by Nathwani, BN, Metter, GE, Gams, RA, Bartolucci, AA, Hartsock, RJ, Neiman, RS, Byrne, GE Jr, Barcos, M, Kim, H, Rappaport, H

“…This retrospective study of diffuse mixed (DM) cell lymphoma was undertaken as a collaborative study between the Repository Center for Lymphoma Clinical…”
Get full text

Chemotherapy of advanced prostatic cancer with adriamycin, BCNU, and cyclophosphamide by Presant, C A, Van Amburg, 3rd, A, Klahr, C, Metter, G E

“…A phase II trial of Adriamycin, BCNU, and cyclophosphamide was performed in 29 patients with advanced prostatic carcinoma (Southeastern Cancer Study Group…”
Get more information

Serum levels of carcinoembryonic antigen and a tumor-extracted carcinoembryonic antigen-related antigen in cancer patients by Shively, J E, Spayth, V, Chang, F F, Metter, G E, Klein, L, Presant, C A, Todd, C W

“…Levels of carcinoembryonic antigen (CEA) and a tumor-extracted CEA-related antigen (TEX) were determined in sera from patients with carcinomas of the breast,…”
Get full text

Adjuvant chemotherapy with 5-fluorouracil after surgical resection of colorectal carcinoma (COG protocol 7041). A preliminary report by Grage, T D, Metter, G E, Cornell, G N, Strawitz, J G, Hill, G J, Frelick, R W, Moss, S E

“…In a prospectively randomized study the effect of adjuvant chemotherapy with 5-FU on survival and recurrence was analyzed in 274 evaluable patients with…”
Get more information